Lymphoma Drug Gets Trio of FDA Approvals

WASHINGTON (MedPage Today) -- The FDA has approved the novel agent idelalisib for treatment of three types of lymphoma in the relapse setting. via MedPageToday.com - medical news plus CME for physicians Read More Here..